Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 27 | 2024 | 1068 | 4.970 |
Why?
|
| Transcription Factors | 18 | 2019 | 722 | 3.580 |
Why?
|
| Cathepsin L | 7 | 2019 | 16 | 2.550 |
Why?
|
| Vitis | 4 | 2019 | 37 | 1.940 |
Why?
|
| Homeodomain Proteins | 5 | 2019 | 144 | 1.690 |
Why?
|
| Plant Extracts | 5 | 2019 | 303 | 1.680 |
Why?
|
| Cell Line, Tumor | 29 | 2024 | 2598 | 1.600 |
Why?
|
| HMGA2 Protein | 2 | 2024 | 5 | 1.480 |
Why?
|
| Repressor Proteins | 3 | 2019 | 267 | 1.380 |
Why?
|
| Cell Nucleus | 4 | 2020 | 383 | 1.340 |
Why?
|
| Cell Movement | 16 | 2020 | 640 | 1.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2024 | 933 | 1.170 |
Why?
|
| Bone Neoplasms | 4 | 2019 | 48 | 1.120 |
Why?
|
| Breast Neoplasms | 10 | 2023 | 1679 | 1.090 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 233 | 1.070 |
Why?
|
| Reactive Oxygen Species | 5 | 2024 | 518 | 0.930 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 330 | 0.900 |
Why?
|
| Oxidative Stress | 7 | 2024 | 990 | 0.860 |
Why?
|
| Serpins | 4 | 2012 | 29 | 0.830 |
Why?
|
| Thiazoles | 2 | 2014 | 76 | 0.790 |
Why?
|
| Cell Adhesion | 5 | 2020 | 237 | 0.770 |
Why?
|
| Male | 31 | 2025 | 22779 | 0.740 |
Why?
|
| Indoles | 2 | 2014 | 178 | 0.740 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 134 | 0.720 |
Why?
|
| Subcellular Fractions | 3 | 2017 | 79 | 0.710 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 97 | 0.680 |
Why?
|
| Humans | 42 | 2025 | 42163 | 0.650 |
Why?
|
| Protease Inhibitors | 2 | 2017 | 53 | 0.640 |
Why?
|
| Epithelial Cells | 7 | 2012 | 426 | 0.620 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 3 | 0.620 |
Why?
|
| Peroxidase | 1 | 2019 | 57 | 0.610 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 78 | 0.590 |
Why?
|
| Cell Proliferation | 9 | 2020 | 1420 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2015 | 297 | 0.580 |
Why?
|
| Signal Transduction | 11 | 2019 | 2111 | 0.570 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 120 | 0.570 |
Why?
|
| Mesoderm | 5 | 2017 | 73 | 0.570 |
Why?
|
| Neoplasm Invasiveness | 8 | 2017 | 284 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2014 | 100 | 0.560 |
Why?
|
| beta Karyopherins | 1 | 2017 | 4 | 0.550 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 14 | 0.540 |
Why?
|
| Prostate | 3 | 2018 | 152 | 0.530 |
Why?
|
| Dipeptides | 1 | 2017 | 31 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 189 | 0.510 |
Why?
|
| Apoptosis | 9 | 2020 | 1541 | 0.490 |
Why?
|
| Cadherins | 5 | 2018 | 102 | 0.480 |
Why?
|
| Autophagy | 1 | 2016 | 136 | 0.470 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 74 | 0.450 |
Why?
|
| Mice, Nude | 5 | 2019 | 403 | 0.440 |
Why?
|
| RNA, Small Interfering | 4 | 2019 | 436 | 0.440 |
Why?
|
| Cathepsin D | 1 | 2014 | 17 | 0.430 |
Why?
|
| Cell Survival | 5 | 2020 | 934 | 0.430 |
Why?
|
| Superoxides | 1 | 2014 | 57 | 0.420 |
Why?
|
| RANK Ligand | 3 | 2015 | 19 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2011 | 136 | 0.400 |
Why?
|
| Arabidopsis | 1 | 2014 | 102 | 0.390 |
Why?
|
| Sesquiterpenes | 1 | 2012 | 38 | 0.380 |
Why?
|
| Transfection | 6 | 2012 | 526 | 0.350 |
Why?
|
| Integrins | 1 | 2011 | 54 | 0.350 |
Why?
|
| Chromogranin A | 1 | 2010 | 7 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2025 | 1066 | 0.330 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 33 | 0.330 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 222 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 534 | 0.330 |
Why?
|
| Mice | 7 | 2020 | 6490 | 0.330 |
Why?
|
| Proteins | 2 | 2003 | 383 | 0.320 |
Why?
|
| Cell Differentiation | 2 | 2010 | 633 | 0.320 |
Why?
|
| Breast | 2 | 2018 | 139 | 0.310 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 599 | 0.300 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2008 | 165 | 0.280 |
Why?
|
| Disease Progression | 6 | 2018 | 661 | 0.280 |
Why?
|
| Carcinoma | 1 | 2008 | 106 | 0.270 |
Why?
|
| Phosphorylation | 5 | 2019 | 973 | 0.270 |
Why?
|
| Feedback, Physiological | 2 | 2017 | 32 | 0.260 |
Why?
|
| RNA Interference | 3 | 2019 | 246 | 0.250 |
Why?
|
| Gene Silencing | 2 | 2020 | 154 | 0.250 |
Why?
|
| Animals | 10 | 2020 | 16695 | 0.250 |
Why?
|
| Pyridines | 2 | 2019 | 134 | 0.250 |
Why?
|
| Proteomics | 2 | 2019 | 363 | 0.240 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2016 | 76 | 0.230 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 35 | 0.230 |
Why?
|
| Cell Communication | 2 | 2020 | 110 | 0.220 |
Why?
|
| Lipid Peroxidation | 1 | 2024 | 141 | 0.210 |
Why?
|
| Caspase 3 | 2 | 2016 | 226 | 0.210 |
Why?
|
| Vimentin | 2 | 2018 | 38 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2014 | 78 | 0.200 |
Why?
|
| Time Factors | 5 | 2014 | 1848 | 0.190 |
Why?
|
| Receptors, Androgen | 4 | 2014 | 144 | 0.190 |
Why?
|
| Osteoclasts | 2 | 2015 | 28 | 0.190 |
Why?
|
| Extracellular Matrix | 3 | 2012 | 129 | 0.190 |
Why?
|
| Tyrosine | 1 | 2002 | 119 | 0.190 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 290 | 0.180 |
Why?
|
| Poverty | 1 | 2025 | 395 | 0.180 |
Why?
|
| Capacity Building | 1 | 2022 | 99 | 0.180 |
Why?
|
| Protein Transport | 3 | 2020 | 295 | 0.170 |
Why?
|
| Female | 9 | 2025 | 24018 | 0.170 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 979 | 0.170 |
Why?
|
| Community-Institutional Relations | 1 | 2022 | 208 | 0.170 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 15 | 0.160 |
Why?
|
| Tyrphostins | 1 | 2019 | 15 | 0.150 |
Why?
|
| Egtazic Acid | 1 | 2019 | 14 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 135 | 0.150 |
Why?
|
| Durapatite | 1 | 2019 | 18 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 188 | 0.150 |
Why?
|
| Metabolomics | 1 | 2019 | 90 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2016 | 534 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2016 | 452 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 649 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 115 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 254 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 573 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 60 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 686 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2010 | 103 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 100 | 0.130 |
Why?
|
| Caspase 12 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Tissue Distribution | 1 | 2017 | 230 | 0.130 |
Why?
|
| Chloroquine | 1 | 2016 | 19 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2010 | 884 | 0.130 |
Why?
|
| Cathepsins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cell Line | 1 | 2020 | 1416 | 0.130 |
Why?
|
| Cystatin C | 1 | 2016 | 25 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2017 | 122 | 0.130 |
Why?
|
| Leucine | 1 | 2016 | 30 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2023 | 705 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 59 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 487 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2015 | 247 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2014 | 141 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.120 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 17 | 0.120 |
Why?
|
| Hazardous Substances | 1 | 2015 | 18 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2015 | 41 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2015 | 57 | 0.110 |
Why?
|
| Models, Biological | 2 | 2017 | 711 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2005 | 61 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 683 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 230 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2013 | 59 | 0.110 |
Why?
|
| Gene Expression | 3 | 2012 | 692 | 0.110 |
Why?
|
| Cytokines | 1 | 2018 | 661 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 115 | 0.100 |
Why?
|
| Imidazoles | 1 | 2014 | 138 | 0.100 |
Why?
|
| Lysosomes | 1 | 2014 | 88 | 0.100 |
Why?
|
| Protein Binding | 1 | 2017 | 1076 | 0.100 |
Why?
|
| Neurons | 1 | 2020 | 1246 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1112 | 0.100 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 19 | 0.100 |
Why?
|
| Caspase 7 | 1 | 2012 | 18 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2014 | 462 | 0.100 |
Why?
|
| Rats | 1 | 2020 | 3701 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2020 | 355 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 173 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 233 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2803 | 0.090 |
Why?
|
| Integrin alpha2 | 1 | 2011 | 3 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 2 | 0.090 |
Why?
|
| Middle Aged | 3 | 2025 | 11819 | 0.090 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 129 | 0.090 |
Why?
|
| Aged | 2 | 2025 | 7982 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 74 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 196 | 0.080 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 18 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.080 |
Why?
|
| Androgens | 1 | 2010 | 107 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2009 | 12 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2008 | 506 | 0.080 |
Why?
|
| Antioxidants | 1 | 2012 | 439 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2008 | 23 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 69 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2008 | 158 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 97 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 81 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2006 | 19 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2008 | 195 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2006 | 54 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1617 | 0.060 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 7 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 146 | 0.060 |
Why?
|
| Neoplasms | 1 | 2015 | 1341 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 287 | 0.050 |
Why?
|
| Kenya | 1 | 2023 | 56 | 0.050 |
Why?
|
| p21-Activated Kinases | 1 | 2003 | 18 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 27 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 47 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 774 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 51 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2023 | 141 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 115 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 13458 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 427 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 457 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 2020 | 44 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 309 | 0.040 |
Why?
|
| Inflammation | 1 | 2025 | 729 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2022 | 359 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2022 | 336 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 539 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2020 | 348 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 729 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 928 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 154 | 0.030 |
Why?
|
| Child | 1 | 2023 | 3381 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2014 | 29 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 159 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 85 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 193 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 207 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 79 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 74 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 181 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2009 | 90 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 70 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 148 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 177 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 149 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 247 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 228 | 0.020 |
Why?
|
| Clone Cells | 1 | 2006 | 50 | 0.020 |
Why?
|
| Environment | 1 | 2006 | 148 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 10 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 57 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1265 | 0.010 |
Why?
|